These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38837660)
1. Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader-Willi syndrome. Schmok T; Surampalli A; Khare M; Zandihaghighi S; Baghbaninogourani R; Patolia B; Gold JA; Naidu A; Cassidy SB; Kimonis VE Am J Med Genet A; 2024 Oct; 194(10):e63724. PubMed ID: 38837660 [TBL] [Abstract][Full Text] [Related]
2. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index. Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492 [TBL] [Abstract][Full Text] [Related]
3. Molecular subtype and growth hormone effects on dysmorphology in Prader-Willi syndrome. Oldzej J; Manazir J; Gold JA; Mahmoud R; Osann K; Flodman P; Cassidy SB; Kimonis VE Am J Med Genet A; 2020 Jan; 182(1):169-175. PubMed ID: 31782896 [TBL] [Abstract][Full Text] [Related]
4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Whitman BY; Myers S; Carrel A; Allen D Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245 [TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335 [TBL] [Abstract][Full Text] [Related]
6. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676 [TBL] [Abstract][Full Text] [Related]
7. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome. Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437 [TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone treatment on thyroid function in pediatric patients with Prader-Willi syndrome. Oto Y; Murakami N; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T Am J Med Genet A; 2020 Apr; 182(4):659-663. PubMed ID: 32011826 [TBL] [Abstract][Full Text] [Related]
9. Thyroid function from birth to adolescence in Prader-Willi syndrome. Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517 [TBL] [Abstract][Full Text] [Related]
10. Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients. Iughetti L; Vivi G; Balsamo A; Corrias A; Crinò A; Delvecchio M; Gargantini L; Greggio NA; Grugni G; Hladnik U; Pilotta A; Ragusa L; Salvatoni A; Wasniewska M; Weber G; Predieri B J Pediatr Endocrinol Metab; 2019 Feb; 32(2):159-165. PubMed ID: 30703060 [TBL] [Abstract][Full Text] [Related]
11. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Bittel DC; Kibiryeva N; Butler MG Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806 [TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone levels in children with Prader-Willi syndrome: a randomized controlled growth hormone trial and 10-year growth hormone study. Trueba-Timmermans DJ; Grootjen LN; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS Eur J Endocrinol; 2024 Aug; 191(2):126-133. PubMed ID: 39049789 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome. Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome. Butler MG; Roberts J; Hayes J; Tan X; Manzardo AM Am J Med Genet A; 2013 Jul; 161A(7):1647-53. PubMed ID: 23696513 [TBL] [Abstract][Full Text] [Related]
15. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Höybye C Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552 [TBL] [Abstract][Full Text] [Related]
16. A girl with incomplete Prader-Willi syndrome and negative MS-PCR, found to have mosaic maternal UPD-15 at SNP array. Morandi A; Bonnefond A; Lobbens S; Carotenuto M; Del Giudice EM; Froguel P; Maffeis C Am J Med Genet A; 2015 Nov; 167A(11):2720-6. PubMed ID: 26109092 [TBL] [Abstract][Full Text] [Related]
17. One-year follow-up of thyroid function in 23 infants with Prader- Willi syndrome at a single center in China. Yang M; Ye J; Han L; Qiu W; Yu Y; Gu X; Zhang H Intractable Rare Dis Res; 2021 Aug; 10(3):198-201. PubMed ID: 34466342 [TBL] [Abstract][Full Text] [Related]
18. Genetic subtypes and phenotypic characteristics of 110 patients with Prader-Willi syndrome. Zhang L; Liu X; Zhao Y; Wang Q; Zhang Y; Gao H; Zhang B; Cui W; Zhao Y Ital J Pediatr; 2022 Jul; 48(1):121. PubMed ID: 35870983 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome. Dağdeviren Çakır A; Baş F; Akın O; Şıklar Z; Özcabı B; Berberoğlu M; Kardelen AD; Bayramoğlu E; Poyrazoğlu Ş; Aydın M; Törel Ergür A; Gökşen D; Bolu S; Aycan Z; Tüysüz B; Ercan O; Evliyaoğlu O J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):308-319. PubMed ID: 33565750 [TBL] [Abstract][Full Text] [Related]